{"DataElement":{"publicId":"3666854","version":"1","preferredName":"Bladder Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Tumor T Stage","preferredDefinition":"Extent of the primary urinary bladder cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"2190136v1.0:3666853v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2190136","version":"1","preferredName":"Bladder Tumor Clinical T Stage","preferredDefinition":"Information related to the clinical T stage of a bladder tumor.","longName":"BLAD_TUMOR_C_T","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206698","version":"1","preferredName":"Bladder Neoplasm","preferredDefinition":"A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12414:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-008F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E6D3302C-2D93-33F5-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-19","modifiedBy":"TAYLORT","dateModified":"2018-11-28","changeDescription":"10/9/17 tt transferred context/BC; added Reg Status.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3666853","version":"1","preferredName":"Bladder Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical T Stage","preferredDefinition":"A clinical finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v7 classification system.  Primary tumor assessment includes bimanual examination under anesthesia before and after endoscopic surgery (biopsy or transurethral resection) and histologic verification of the presence or absence of tumor when indicated.  Appropriate imaging techniques for extravesical extension of the primary tumor and lymph node evaluation should be incorporated into clinical staging. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3666853v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T0","valueDescription":"Bladder Cancer pT0 TNM Finding","ValueMeaning":{"publicId":"3361794","version":"1","preferredName":"Bladder Cancer pT0 TNM Finding","longName":"3361794","preferredDefinition":"Bladder cancer in which there is no evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT0 TNM Finding v6 and v7","conceptCode":"C61206","definition":"Bladder cancer in which there is no evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7474902-F11B-3AC9-E040-BB89AD434205","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D46E9B58-95E8-68BE-E040-BB89AD433B0D","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"ONEDATA","dateModified":"2013-01-29","deletedIndicator":"No"},{"value":"T1","valueDescription":"Bladder Cancer pT1 TNM Finding","ValueMeaning":{"publicId":"3361796","version":"1","preferredName":"Bladder Cancer pT1 TNM Finding","longName":"3361796","preferredDefinition":"Bladder cancer with tumor invading subepithelial connective tissue. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT1 TNM Finding v6 and v7","conceptCode":"C61209","definition":"Bladder cancer with tumor invading subepithelial connective tissue. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7474902-F141-3AC9-E040-BB89AD434205","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D46E9B58-95F2-68BE-E040-BB89AD433B0D","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"ONEDATA","dateModified":"2013-01-29","deletedIndicator":"No"},{"value":"T2","valueDescription":"Bladder Cancer pT2 TNM Finding v7","ValueMeaning":{"publicId":"3361798","version":"1","preferredName":"Bladder Cancer pT2 TNM Finding v7","longName":"3361798","preferredDefinition":"Bladder cancer with tumor invading the muscularis propria. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT2 TNM Finding v7","conceptCode":"C89352","definition":"Bladder cancer with tumor invading the muscularis propria. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7474902-F167-3AC9-E040-BB89AD434205","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D46E9B58-95FC-68BE-E040-BB89AD433B0D","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"ONEDATA","dateModified":"2013-01-29","deletedIndicator":"No"},{"value":"T3","valueDescription":"Bladder Cancer pT3 TNM Finding","ValueMeaning":{"publicId":"3361804","version":"1","preferredName":"Bladder Cancer pT3 TNM Finding","longName":"3361804","preferredDefinition":"Bladder cancer with tumor invading the perivesical tissue. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT3 TNM Finding v6 and v7","conceptCode":"C61213","definition":"Bladder cancer with tumor invading the perivesical tissue. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7474902-F1D9-3AC9-E040-BB89AD434205","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D46E9B58-9606-68BE-E040-BB89AD433B0D","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"ONEDATA","dateModified":"2013-01-29","deletedIndicator":"No"},{"value":"T4","valueDescription":"Bladder Cancer pT4 TNM Finding v7","ValueMeaning":{"publicId":"3361810","version":"1","preferredName":"Bladder Cancer pT4 TNM Finding v7","longName":"3361810","preferredDefinition":"Bladder cancer with tumor invading any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT4 TNM Finding v7","conceptCode":"C89355","definition":"Bladder cancer with tumor invading any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7474902-F24B-3AC9-E040-BB89AD434205","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D46E9B58-9610-68BE-E040-BB89AD433B0D","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"ONEDATA","dateModified":"2013-01-29","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Bladder Cancer pT4a TNM Finding v7","ValueMeaning":{"publicId":"3361812","version":"1","preferredName":"Bladder Cancer pT4a TNM Finding v7","longName":"3361812","preferredDefinition":"Bladder cancer with tumor invading prostatic stroma, uterus, vagina.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT4a TNM Finding v7","conceptCode":"C89356","definition":"Bladder cancer with tumor invading prostatic stroma, uterus, vagina.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7474902-F271-3AC9-E040-BB89AD434205","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D46E9B58-961A-68BE-E040-BB89AD433B0D","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"ONEDATA","dateModified":"2013-01-29","deletedIndicator":"No"},{"value":"T4b","valueDescription":"Bladder Cancer pT4b TNM Finding","ValueMeaning":{"publicId":"3361820","version":"1","preferredName":"Bladder Cancer pT4b TNM Finding","longName":"3361820","preferredDefinition":"Bladder cancer with tumor invading pelvic wall, abdominal wall. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pT4b TNM Finding v6 and v7","conceptCode":"C61218","definition":"Bladder cancer with tumor invading pelvic wall, abdominal wall. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7474902-F309-3AC9-E040-BB89AD434205","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D46E9B58-9624-68BE-E040-BB89AD433B0D","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"ONEDATA","dateModified":"2013-01-29","deletedIndicator":"No"},{"value":"Ta","valueDescription":"Bladder Cancer pTa TNM Finding","ValueMeaning":{"publicId":"3361814","version":"1","preferredName":"Bladder Cancer pTa TNM Finding","longName":"3361814","preferredDefinition":"Bladder cancer with a finding of noninvasive papillary carcinoma. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pTa TNM Finding v6 and v7","conceptCode":"C61207","definition":"Bladder cancer with a finding of noninvasive papillary carcinoma. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7474902-F297-3AC9-E040-BB89AD434205","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D46E9B58-962E-68BE-E040-BB89AD433B0D","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"ONEDATA","dateModified":"2013-01-29","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Bladder Cancer pTis TNM Finding","ValueMeaning":{"publicId":"3361816","version":"1","preferredName":"Bladder Cancer pTis TNM Finding","longName":"3361816","preferredDefinition":"Bladder cancer with a finding of carcinoma in situ: 'flat tumor'. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pTis TNM Finding v6 and v7","conceptCode":"C61208","definition":"Bladder cancer with a finding of carcinoma in situ: 'flat tumor'. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7474902-F2BD-3AC9-E040-BB89AD434205","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D46E9B58-9638-68BE-E040-BB89AD433B0D","beginDate":"2010-09-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"ONEDATA","dateModified":"2013-01-29","deletedIndicator":"No"},{"value":"TX","valueDescription":"Bladder Cancer pTX TNM Finding","ValueMeaning":{"publicId":"3361818","version":"1","preferredName":"Bladder Cancer pTX TNM Finding","longName":"3361818","preferredDefinition":"Bladder cancer in which the primary tumor cannot be assessed. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pTX TNM Finding v6 and v7","conceptCode":"C61205","definition":"Bladder cancer in which the primary tumor cannot be assessed. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B7474902-F2E3-3AC9-E040-BB89AD434205","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D46E9B58-9642-68BE-E040-BB89AD433B0D","beginDate":"2010-09-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"ONEDATA","dateModified":"2013-01-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3666852","version":"1","preferredName":"Bladder Cancer Clinical TNM Finding v7 American Joint Committee on Cancer T Stage Stage","preferredDefinition":"A clinical finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v7 classification system.  Primary tumor assessment includes bimanual examination under anesthesia before and after endoscopic surgery (biopsy or transurethral resection) and histologic verification of the presence or absence of tumor when indicated.  Appropriate imaging techniques for extravesical extension of the primary tumor and lymph node evaluation should be incorporated into clinical staging. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89362:C39315:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer Clinical TNM Finding v7","conceptCode":"C89362","definition":"A clinical finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v7 classification system.  Primary tumor assessment includes bimanual examination under anesthesia before and after endoscopic surgery (biopsy or transurethral resection) and histologic verification of the presence or absence of tumor when indicated.  Appropriate imaging techniques for extravesical extension of the primary tumor and lymph node evaluation should be incorporated into clinical staging. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D46E9B58-95BF-68BE-E040-BB89AD433B0D","latestVersionIndicator":"Yes","beginDate":"2013-01-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"ONEDATA","dateModified":"2013-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D46E9B58-95D0-68BE-E040-BB89AD433B0D","latestVersionIndicator":"Yes","beginDate":"2013-01-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"COOPERM","dateModified":"2013-01-29","changeDescription":"Created for CRF standard harmonization staging maintenance. mc 1/29/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"10000198","version":"1","longName":"Bladder","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000199","version":"1","longName":"Bladder","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"SWOG","type":"USED_BY","context":"SWOG"},{"name":"AJCCT","type":"OID, SWOG","context":"SWOG"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"Bladder_Ca_Clin_T_Stage","type":"Context Short Name","context":"NRG"},{"name":"CLSTGT","type":"Synonym","context":"NCIP"}],"ReferenceDocuments":[{"name":"Clinical T Stage","type":"Preferred Question Text","description":"Clinical T Stage","url":null,"context":"NCI Standards"},{"name":"Clinical T Stage","type":"Alternate Question Text","description":"T","url":null,"context":"SWOG"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"D46ECBC1-B447-239D-E040-BB89AD437084","latestVersionIndicator":"Yes","beginDate":"2013-01-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-29","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created to replace generic VD including Pathologic T values. mc 1/29/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}